Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,032 | 38 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $418.78 | 12 | $0 (2018) |
| Allergan Inc. | $125.82 | 2 | $0 (2017) |
| Neurocrine Biosciences, Inc. | $107.72 | 1 | $0 (2017) |
| Alkermes, Inc. | $91.79 | 5 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $69.64 | 5 | $0 (2022) |
| Lundbeck LLC | $46.61 | 3 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $43.41 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $24.34 | 1 | $0 (2024) |
| Tris Pharma Inc | $18.98 | 1 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $15.89 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $117.78 | 6 | Lundbeck LLC ($32.25) |
| 2023 | $50.05 | 3 | Alkermes, Inc. ($31.07) |
| 2022 | $77.24 | 5 | Otsuka America Pharmaceutical, Inc. ($38.45) |
| 2021 | $48.80 | 3 | Alkermes, Inc. ($18.86) |
| 2020 | $27.66 | 2 | Otsuka America Pharmaceutical, Inc. ($16.35) |
| 2019 | $14.36 | 1 | Lundbeck LLC ($14.36) |
| 2018 | $338.30 | 9 | Sunovion Pharmaceuticals Inc. ($306.99) |
| 2017 | $357.36 | 9 | Allergan Inc. ($125.82) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $24.34 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.72 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.53 | General |
| Category: PSYCHIATRY | ||||||
| 07/25/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: CNS | ||||||
| 02/08/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Neurology | ||||||
| 10/19/2023 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: ADHD | ||||||
| 03/23/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: CNS | ||||||
| 02/09/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: CNS | ||||||
| 12/07/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: PSYCHIATRY | ||||||
| 10/13/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: CNS | ||||||
| 09/15/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: PSYCHIATRY | ||||||
| 05/24/2022 | Janssen Pharmaceuticals, Inc | INVEGA TRINZA (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Neuroscience | ||||||
| 05/05/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: CNS | ||||||
| 04/08/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: PSYCHIATRY | ||||||
| 01/10/2019 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.36 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $123.73 | General |
| Category: CNS | ||||||
| 09/13/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $4.78 | General |
| Category: CNS | ||||||
| 08/23/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: CNS | ||||||
| 06/28/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: CNS | ||||||
| 05/24/2018 | Vanda Pharmaceuticals Inc. | Hetlioz (Drug), Fanapt | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Non-24-Hour Sleep-Wake Disorder | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 49 | 106 | $13,584 | $7,235 |
| 2022 | 2 | 58 | 111 | $11,177 | $6,626 |
| 2021 | 3 | 73 | 155 | $15,255 | $9,289 |
| 2020 | 3 | 89 | 175 | $17,659 | $9,335 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 66 | $8,250 | $5,229 | 63.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 40 | $5,334 | $2,006 | 37.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 72 | $8,968 | $5,483 | 61.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 39 | $2,208 | $1,144 | 51.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 75 | $9,238 | $6,030 | 65.3% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 15 | 33 | $4,125 | $2,069 | 50.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 47 | $1,892 | $1,189 | 62.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 38 | 83 | $10,476 | $5,449 | 52.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 26 | 40 | $5,255 | $2,739 | 52.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 52 | $1,928 | $1,147 | 59.5% |
About Dr. Michael Moeller, MD
Dr. Michael Moeller, MD is a Psychiatry healthcare provider based in Mankato, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598765877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Moeller, MD has received a total of $1,032 in payments from pharmaceutical and medical device companies, with $117.78 received in 2024. These payments were reported across 38 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,032).
As a Medicare-enrolled provider, Moeller has provided services to 269 Medicare beneficiaries, totaling 547 services with total Medicare billing of $32,485. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Mankato, MN
- Active Since 07/28/2005
- Last Updated 10/01/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598765877
Products in Payments
- LATUDA (Drug) $418.78
- VRAYLAR (Drug) $140.53
- INGREZZA (Drug) $107.72
- REXULTI (Drug) $99.90
- ARISTADA (Drug) $55.77
- LYBALVI (Drug) $36.02
- FANAPT (Drug) $26.94
- COBENFY (Drug) $24.34
- Dyanavel XR (Drug) $18.98
- Hetlioz (Drug) $16.47
- ABILIFY MAINTENA (Drug) $16.35
- UZEDY (Drug) $15.89
- INVEGA TRINZA (Drug) $15.29
- CAPLYTA (Drug) $15.23
- NUPLAZID (Drug) $12.03
- VYVANSE (Drug) $11.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Mankato
Dr. Danielle Magness-Wellmann, Do, DO
Psychiatry — Payments: $179,693
Edward Sathoff, Md, MD
Psychiatry — Payments: $1,265
Robert Olson, Md, MD
Psychiatry — Payments: $1,003
Sreelatha Spieker, Md, MD
Psychiatry — Payments: $802.50
Veronica Radigan, M.d, M.D
Psychiatry — Payments: $510.47
Dr. Travis Hansen, M.d, M.D
Psychiatry — Payments: $341.71